Burt RK, Loh Y, Stefosky D, et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurology. 2009;8(3):244-253.
Mancardi GL, Sormani MP, Gualandi F, et al. Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial. Neurology. 2015;84(10):981-988.
Minden SL, Feinstein A, et al. Evidence-based guidelines: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014 Jan 14;82(2):174-181.
Motl RW, Pilutti LA. The benefits of exercise training in multiple sclerosis. Nat Rev Neurol. 2012;8(9):487-497.
Multiple sclerosis (MS). EBSCO DynaMed Plus website. Available at:https://www.dynamed.com/topics/dmp~AN~T116285/Multiple-sclerosis-MS. Updated July 23, 2018. Accessed September 26, 2018.
Nash RA, Hutton GJ, Racke MK, et al. Hig-dose immunosuppressive therapy and autologous hematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report. JAMA Neurology. 2015;72(2):159-169.
NINDS multiple sclerosis information page. National Institute of Neurological Disorders and Stroke website. Available at: https://www.ninds.nih.gov/Disorders/All-Disorders/Multiple-Sclerosis-Information-Page. Accessed September 27, 2018.
Northwestern University. Stem cell transplant reverses early-stage multiple sclerosis. Science Daily website. Available at: http://www.sciencedaily.com/releases/2009/01/090129213441.htm. Accessed September 27, 2018.
What is MS? National Multiple Sclerosis Society website. Available at: http://www.nationalmssociety.org/What-is-MS. Accessed September 27, 2018.